Literature DB >> 27166519

The bioengineered kidney: science or science fiction?

Leif Oxburgh1, Thomas J Carroll.   

Abstract

PURPOSE OF REVIEW: This article gives an overview of important new advances relating to kidney bioengineering. RECENT
FINDINGS: Directed differentiation studies have shown that proximal tubules, distal tubules, podocytes, collecting ducts, interstitium and endothelial cells can be generated from patient-derived stem cells using standardized protocols. One caveat to the interpretation of these studies is that the physiological characteristics of differentiated cells remain to be defined. Another important area of progress is scaffolding. Both decellularized organs and polymeric materials are being used as platforms for three-dimensional growth of kidney tissue, and key distinctions between these approaches are discussed.
SUMMARY: In the past 3 years, it has become clear that building kidney tissue is feasible. The laboratory-grown kidney is an attainable goal if efforts are focused on refining directed differentiation procedures to optimize cell function and on developing scaffolding strategies that ensure physiological function at the tissue level.

Entities:  

Mesh:

Year:  2016        PMID: 27166519      PMCID: PMC4894549          DOI: 10.1097/MNH.0000000000000235

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  22 in total

1.  Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis.

Authors:  Minoru Takasato; Pei X Er; Han S Chiu; Barbara Maier; Gregory J Baillie; Charles Ferguson; Robert G Parton; Ernst J Wolvetang; Matthias S Roost; Susana M Chuva de Sousa Lopes; Melissa H Little
Journal:  Nature       Date:  2015-10-07       Impact factor: 49.962

2.  Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney.

Authors:  M Takasato; P X Er; M Becroft; J M Vanslambrouck; E G Stanley; A G Elefanty; M H Little
Journal:  Nat Cell Biol       Date:  2013-12-15       Impact factor: 28.824

3.  Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells.

Authors:  Tongbiao Zhao; Zhen-ning Zhang; Peter D Westenskow; Dilyana Todorova; Zheng Hu; Tongxiang Lin; Zhili Rong; Jinchul Kim; Jingjin He; Meiyan Wang; Dennis O Clegg; Yong-guang Yang; Kun Zhang; Martin Friedlander; Yang Xu
Journal:  Cell Stem Cell       Date:  2015-08-20       Impact factor: 24.633

Review 4.  Renal cell therapy and beyond.

Authors:  Joon Ho Song; H David Humes
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

5.  Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells.

Authors:  Shin-Ichi Mae; Akemi Shono; Fumihiko Shiota; Tetsuhiko Yasuno; Masatoshi Kajiwara; Nanaka Gotoda-Nishimura; Sayaka Arai; Aiko Sato-Otubo; Taro Toyoda; Kazutoshi Takahashi; Naoki Nakayama; Chad A Cowan; Takashi Aoi; Seishi Ogawa; Andrew P McMahon; Shinya Yamanaka; Kenji Osafune
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment.

Authors:  Kyung-Jin Jang; Ali Poyan Mehr; Geraldine A Hamilton; Lori A McPartlin; Seyoon Chung; Kahp-Yang Suh; Donald E Ingber
Journal:  Integr Biol (Camb)       Date:  2013-09       Impact factor: 2.192

7.  Cellular senescence limits regenerative capacity and allograft survival.

Authors:  Heidi Braun; Bernhard M W Schmidt; Mirja Raiss; Arpita Baisantry; Dan Mircea-Constantin; Shijun Wang; Marie-Luise Gross; Manuel Serrano; Roland Schmitt; Anette Melk
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

Review 8.  Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.

Authors:  Martijn J Wilmer; Chee Ping Ng; Henriëtte L Lanz; Paul Vulto; Laura Suter-Dick; Rosalinde Masereeuw
Journal:  Trends Biotechnol       Date:  2015-12-18       Impact factor: 19.536

9.  Dissecting engineered cell types and enhancing cell fate conversion via CellNet.

Authors:  Samantha A Morris; Patrick Cahan; Hu Li; Anna M Zhao; Adrianna K San Roman; Ramesh A Shivdasani; James J Collins; George Q Daley
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

10.  Regeneration and experimental orthotopic transplantation of a bioengineered kidney.

Authors:  Jeremy J Song; Jacques P Guyette; Sarah E Gilpin; Gabriel Gonzalez; Joseph P Vacanti; Harald C Ott
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

View more
  3 in total

1.  The Wearable Artificial Kidney.

Authors:  George M Dolson
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Oct-Dec

2.  Essential design considerations for the resazurin reduction assay to noninvasively quantify cell expansion within perfused extracellular matrix scaffolds.

Authors:  Joseph S Uzarski; Michael D DiVito; Jason A Wertheim; William M Miller
Journal:  Biomaterials       Date:  2017-02-16       Impact factor: 12.479

3.  Flow-enhanced vascularization and maturation of kidney organoids in vitro.

Authors:  Kimberly A Homan; Navin Gupta; Katharina T Kroll; David B Kolesky; Mark Skylar-Scott; Tomoya Miyoshi; Donald Mau; M Todd Valerius; Thomas Ferrante; Joseph V Bonventre; Jennifer A Lewis; Ryuji Morizane
Journal:  Nat Methods       Date:  2019-02-11       Impact factor: 28.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.